Metabolic Profiling of Perfusate from Clinical Ex Vivo Lung Perfusion Yields Potential Biomarkers of Early Lung Transplant Outcomes

2014 ◽  
Vol 33 (4) ◽  
pp. S96-S97 ◽  
Author(s):  
M.K. Hsin ◽  
R. Zamel ◽  
M. Cypel ◽  
K. Hashimoto ◽  
M. Chen ◽  
...  
2021 ◽  
Vol 40 (4) ◽  
pp. S309-S310
Author(s):  
M. Urban ◽  
J. Boudreaux ◽  
H.M. Strah ◽  
B. Small ◽  
D. Berkheim ◽  
...  

Author(s):  
Shuji Okahara ◽  
Bronwyn Levvey ◽  
Mark McDonald ◽  
Rohit D’Costa ◽  
Helen Opdam ◽  
...  

2019 ◽  
Vol 158 (4) ◽  
pp. e149-e152 ◽  
Author(s):  
Marcos Galasso ◽  
Rachel D. Vanderlaan ◽  
Melinda Solomon ◽  
Christopher Caldarone ◽  
Shaf Keshavjee ◽  
...  

2018 ◽  
Vol 31 (12) ◽  
pp. 1405-1417 ◽  
Author(s):  
John R. Spratt ◽  
Lars M. Mattison ◽  
Paul A. Iaizzo ◽  
Carolyn Meyer ◽  
Roland Z. Brown ◽  
...  

2021 ◽  

Ex vivo lung perfusion is an indispensable tool in the armamentarium of any lung transplant center. It helps to increase an already shrinking donor pool by offering a chance to assess suboptimal donor lungs in a systematic manner and improve them by treating them with low-molecular-weight perfusate. We offer a stepwise guide to carry out ex vivo lung perfusion on the donor lungs and criteria to accept them for transplants.


Sign in / Sign up

Export Citation Format

Share Document